POLBF (Poolbeg Pharma) Institutional Ownership: 2.88% (As of Jul. 05, 2026)


What is Poolbeg Pharma Institutional Ownership?

Poolbeg Pharma POLBF Institutional Ownership is 2.88% as of Jul. 05, 2026. The stock has 1 warning sign investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Poolbeg Pharma's institutional ownership is 2.88%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Poolbeg Pharma's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Poolbeg Pharma's Float Percentage Of Total Shares Outstanding is 0.00%.

Poolbeg Pharma Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Poolbeg Pharma's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poolbeg Pharma Institutional Ownership Chart

Poolbeg Pharma Historical Data

The historical data trend for Poolbeg Pharma can be seen below:

2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30
Institutional Ownership 4.92 4.39 2.04 1.51 1.51 1.51 1.51 1.51 1.51 1.51

Poolbeg Pharma Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 2.88% mean?
Poolbeg Pharma (POLBF) has a Institutional Ownership of 2.88% as of Jul. 05, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Poolbeg Pharma and its competitors.
Is Poolbeg Pharma's Institutional Ownership too high?
Poolbeg Pharma's current Institutional Ownership is 2.88%.
How does Poolbeg Pharma's Institutional Ownership compare to VRTX and REGN?
Poolbeg Pharma's Institutional Ownership of 2.88% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Poolbeg Pharma and its competitors. Poolbeg Pharma's current Institutional Ownership is 2.88%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poolbeg Pharma stock overvalued right now?
Poolbeg Pharma (POLBF) has a current Institutional Ownership of 2.88%. The current Institutional Ownership is 2.88%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Poolbeg Pharma (POLBF), the current Institutional Ownership is 2.88% as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Poolbeg Pharma Business Description

Other Exchanges POLB:UK7JN:Germany
Address 20 St. Andrew Street, The Clubhouse Holborn, London, GBR, EC4A 3AG
Poolbeg Pharma PLC is a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field. The Company's main asset, POLB 001, has the potential to expand administration of cancer immunotherapies from centralised specialist cancer centres into community hospitals by making the treatments safer through the prevention of the life-threatening side effect, Cytokine Release Syndrome (CRS). The group is also advancing the development of a patient-friendly therapy for obesity with an oral encapsulated GLP-1, offering a differentiated approach within one of the world's markets. It is focused on partnering its high-value programmes that are targeting large markets and addressing critical unmet medical needs.